Preliminary Program subject to change
15D02 Disease Therapies and Diagnostics
OverviewThe intersection of engineering and biology has facilitated many recent medical advances. This session seeks submissions that address engineering advancements towards the diagnosis and treatment of disease via the implementation of novel techniques, materials, or processes or the novel application of established techniques or materials. Areas of interest include, but are not limited to, innovations in drug design, drug targeting, high throughput screening, biosensors, biomaterials, genetic engineering, and proteomics.
Primary SponsorEngineering Fundamentals in Life Science (15d)
Co-Sponsor(s)Engineering Fundamentals in Life Science (15e)

Chair

Melissa A. Moss
Assistant Professor
Dept. of Chemical Engineering
University of South Carolina
2C02 Swearingen Engineering Center
Columbia, SC 29208
Phone Number: 803-777-5604
Email: mossme@engr.sc.edu

CoChair

Adam T. Capitano
Chemical Engineering
University of Houston
S222 Engineering Bldg 1
Houston, TX 77204-4004
Phone Number: 713-743-4319
Fax Number: 713-743-4323
Email: acapitano@uh.edu
An Injectable Polymeric Device for Drug Delivery and Sensing
Karen Daniel, Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, Grace Kim, Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02142, Christophoros Vassiliou, Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02142, Michael Cima, Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142 and Robert Langer, Chemical Engineering and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142
Application of Immunomagnetic Cell Enrichment in Combination with Rt- Pcr for the Detection of Rare Circulating Cancer Cells in Peripheral Blood and Bone Marrow from Patients with Head and Neck Squamous Cell Carcinoma (Hnscc)
Liying Yang, Department of Chemical and Biomolecular Engin, The Ohio State University, 140 W 19th Ave, Columbus, OH 43220, Xiaodong Tong, Chemical and Biomolecular Engineering, The Ohio State Unversity, 140 W 19th Ave, Columbus, OH 43210, James, Campbell Lang, College of Medicine and Public Heath, The Ohio State University, 300 West 10th Avenue, Columbus, OH 43210, Maciej Zborowski, Department of Biomedical Engineering, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH and Jeffrey J. Chalmers, Department of Chemical Engineering, The Ohio State University, 140 W 19th Ave, Columbus, OH 43210
Cd4+ T-Cell Epitope Identification Using Yeast Displaying Single Chain Class II Mhc Molecules as Artificial Apcs
Fei Wen and Huimin Zhao, Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, 219 RAL, Box C-3 RAL, MC-712, 600 S. Mathews Ave., Urbana, IL 61801
Detection of Active Amyloid-Beta Species Using a Quartz Crystal Microbalance
Joseph A. Kotarek and Melissa A. Moss, Dept. of Chemical Engineering, University of South Carolina, 2C02 Swearingen Engineering Center, Columbia, SC 29208
Break
Development of Novel Sialic Acid Containing Polymers for Use in Alzheimer's Disease
Theresa A. Good1, Dhara Patel2 and Christopher Cowan2, (1)University of Maryland Baltimore County, 1000 Hilltop Circle, ECS 305, Baltimore, MD 21250, (2)Chemical and Biochemical Engineering, University of Maryland Baltimore County, 1000 Hilltop Circle, ECS 305, Baltimore, MD 21250
Assessment of Islet Quality
Anna Pisania, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, Klearchos K. Papas, University of Minnesota, Diabetes Institute for Immunology and Transplantation, MMC 195, 420 Delaware Street SE, Minneapolis, MN 55455, Susan Bonner-Weir, Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, Gordon C. Weir, Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215 and Clark K. Colton, Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Room 66-452, Cambridge, MA 02139
Metabolic Re-Engineering for Obesity Drug Target Identification: Flux Analysis and Gene Profiling of Forced Uncoupling Protein 1 Expression in 3t3-L1 Cells
Yaguang Si1, Santosh Palani2, Fatih Senocak2, Arul Jayaraman2 and Kyongbum Lee3, (1)Biology, Tufts University, 4 Colby Street, Medford, MA 02155, (2)Texas A&M University, Department of Chemical Engineering, 3122 TAMU, College Station, TX 77840, (3)Chemical and Biological Engineering, Tufts University, 4 Colby Street, Room 142, Medford, MA 02155

Food, Pharmaceutical & Bioengineering Division